JACK Archives - Blue Horseshoe Stocks

Markets Crashing, Bears Cashing!

Options Updates:

In these exceptionally volatile times, it’s always good to have both long and short targets, depending on which way the wind is blowing. With the help of yet another bloody day for the markets at large, the bearish ideas we’ve been tracking in MAR all week tacked on some impressive new highs, and the new CYBR Puts we added in fresh for yesterday’s report immediately went exponential.

In the case of MAR, these numbers represent 2-day swings, and for CYBR, we’ve got yesterday’s intraday ranges:

MAR Weekly $86.50-85 Puts
$86.50: 2.80-11.72 (+319%)
$86: 2.70-11.27 (+317%)
$85.50: 2.20-9.07 (+312%)
$85: 2.13-10.00 (+369%)
______

CYBR Weekly $107-104 Puts
$107: 2.70-11.90 (+341%)
$106: 2.80-9.87 (+253%)
$105: 2.26-10.00 (+342%)
$104: 2.40-9.00 (+275%)

With the aforementioned winds once again blowing in a bearish direction this morning, we’ll keep an eye out for even more new highs in these plays. We’ll also add in a related idea for the SPDR S&P 500 ETF, and put the SPY Weekly $280-278 Puts on watch into tomorrow.

New Options Ideas:
EQM Weekly $15-17.50 Calls
JACK Weekly $65-60 Puts
ONEM Weekly $25-22.50 Puts

Extended Watchlist:
SEGN, HENC, SPOM, DECN, CIVX, BCII

Blue Horseshoe Stocks: SPY Recap & More

SPDR S&P500 ETF (SPY)

We were all over the SPY last week, scoring some big chances for profits early on with some calls, and then flipping to the bearish end of things with some puts on Friday, which also happened to work like a charm. We played the SPY like a fiddle, and the potential returns were considerable.

Our targets were the SPY Weekly $263.50-262 Puts, and each of the four contracts contained within that range provided traders with huge gain opportunities, which were as follows:

$263.50 Puts – Range: .75-3.50 – Max Gain: 367%
$263 Puts – Range: .59-3.10 – Max Gain: 425%
$262.50 Puts – Range: .45-3.07 – Max Gain: 582%
$262 Puts – Range: .34-2.16 – Max Gain: 535%

Johnson & Johnson JNJ

We want to place JNJ on longer-term rebound watch today as the stock took an absolute plastering on Friday with roughly a $15 dip. Three separate insiders filed Form-4’s on Friday indicating share purchases at those lows. That is as good an indicator as any that belief is high in JNJ getting back on track in the near future.

We’re going to put the JNJ 01/25 $135-140 Calls on watch in the days and weeks ahead, as a recovery of some degree does not seem far off for JNJ.

Extended Watchlist:
GLBS, IDRA, JACK, YRIV, GSAT(Bottom Play)

Blue Horseshoe Stocks: JACK Update & More

Jack in the Box, Inc. JACK – Update

As a fresh options trading idea on Friday morning, we submitted the Jack 07/20 $80-90 Calls for observation after noticing the company’s solid earnings report and premarket gap-up. Although we passed over the weeklies for the July 20th calls for a bit more of an extended idea, it took no time at all for those contracts to see significant appreciation.

We’re pleased to say that each of the three selected targets produced respectable single-session moves, and will remain on our radar moving forward. Those potential gains were as follows: ,

$80 Calls – Range: 3.70-5.78 – Max Gain: 56%
$85 Calls – Range: 1.42-2.58 – Max Gain: 82%
$90 Calls – Range: .50-.80 – Max Gain: 60%

aTyr Pharma, Inc. LIFE

We noticed that LIFE woke from a slumber late last week, and began to trend off of its annual lows. We’re going to put it on the radar as a potential recovery play. As you can see, the stock was ridiculously oversold heading into last week, following a massive beating from roughly a month ago.

We believe there is a fair chance that the stock could return to the levels from prior to that backslide, which would spell significant gains from the current PPS.

Extended Watchlist:
AQMS, SRE, SNES, CODX, GNW, BIOC, TEUM, PTC

Blue Horseshoe Stocks: FIVE Recap & More

Five Below, Inc. FIVE – Options Recap

The fresh options idea we included in yesterday morning’s premarket report, the FIVE Weekly $90-95 Calls, was related to the company’s Q1 earnings report and strong guidance.

Unsurprisingly, those ideas provided us with solid chances for intraday profits as the stock ran from the $95 to the $100 range on the day. Be aware that despite the odd increments, the following are all of the contracts contained within our listed range. The moves they made were as follows:

$90 Calls – Range: 6.50-10.70 – Max Gain: 65%
$91 Calls – Range: 6.00-8.65 – Max Gain: 44%
$95 Calls – Range: 2.85-6.00 – Max Gain: 111%
____

Another Fresh Idea:
Jack in the Box JACK 07/20 $80-90 Calls

Axovant Sciences, Inc. AXON

This will be third consecutive day we’ve had to mention AXON, which we initially tagged on Wednesday morning following a large group of Form-4 buy on Tuesday. This insiders were obviously pre-informed about the news of an $840M+ licensing deal for AXON’s Parkinson’s gene therapy that would be released the following day.

Our sleuthing gave us a leg-up and our call was timed with precision. We observed a low of 3.27 on Tuesday and yesterday the stock saw a high of 6.59, which represents an excellent three-day swing of 102%

Extended Watchlist:
PAVM, CRMD, CEPU, CRMD, SDRL, HMNY

Blue Horseshoe Stocks: News Update, Options Highlights & More

Aperture Health, Inc. APRE – News Update

Our first order of business this morning is to update our readers on APRE, which we’ve been following for the better part of a month. In that time the stock has provided us with multiple swing trade opportunities and has been stretching the envelope on its latest upswing. From the .0188 swing-low we observed last Wednesday APRE has rapidly gained 219%, running up to a new high of .0599 yesterday.

We’ve pointed out a few key highlights of the current chart on the following snapshot:

We also want to point out some untraded-upon news that hit the wires yesterday post-market:

NEW YORK, May 12, 2016 /PRNewswire/ – Aperture Health, Inc. (OTC Markets.com: APRE) and CSS Alliance LLC (“CSS”), are pleased to announce that the company has branched out and signed a Joint Venture agreement which includes an exclusive worldwide distribution agreement with CSS Korea R&D Co., Ltd for new technologies and products that include solar powered A/C units, and powerless generators, as well as solar powered boilers (>>View Full PR)

Options Highlights

Jack in the Box, Inc. JACK – We had a couple of our active options targets turn up sizable opportunities for profits yesterday beginning with JACK 05/20 $70 and $75 Calls. We caught JACK on the heels of its Q2 earnings release, and various circumstances allowed for us to take advantage of the idea on its first day of mentioning.

The $70 Calls traded in an impressive range from a low of 2.25 on up 6.85 for an intraday gain of 204% The $75 Calls fared even better as they ran from .39 to 1.61, a single-session rip of 313% With performances like those, we’ll continue to track these contracts through to their expiration next week.

______

Macy’s Inc. M – Our signaled range for Macy’s from Wednesday’s report added to its gains yesterday. We had been tracking the M Weekly $36-34 Puts. At the top of the range, the $36 Puts surged from a low of 1.83 up to 5.15, for a two-session swing of 181% Gains increased incrementally into the lower strike prices, culminating in the $34’s which traded up from Wednesday’s low of .50 to a new high of 3.62; a 624% swing.

Cerebain Biotech Corp. CBBT

Just after we were reviewing CBBT’s recent performance in yesterday’s morning report, (We’d added it to our radars last Tuesday) the stock went on to set another new high for us.

The stock traded in a daily range from 1.25-1.75, a respectable 40% intraday rip. From our observed low of .53, the new high represents an overall move of 230%

Extended Watchlist:
QUTR, IMMU, IDRA, XXII, NVDA, MOMO